Galmed and MyBiotics to Collaborate in Development of Bespoke Microbiome Signature for Aramchol; Collaboration Seeks to Enhance Response Rate and Identify Biomarker for Treatment of NASH and Fibrosis

Press/Media

Period9 Nov 2020

Media coverage

6

Media coverage